Eli Lilly and Company (LLY) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

Closelooknet score: 64 out of 100 (momentum 91 · quality 90 · valuation 22), as of 2026-11-11.
Signal: Up 4.3% at the close — Above both trend lines; one of the day's strongest moves. (as of 2026-11-09)
Trend: Eli Lilly and Company trades 15.8% above its 50-day and 28.2% above its 200-day moving average. (as of 2026-11-09)
Index seat: HALO Growth 100

Eli Lilly discovers, develops and markets pharmaceutical products across cardiometabolic health, oncology, immunology and neuroscience, including insulin lines, Mounjaro, Trulicity, Zepbound, Verzenio and Ebglyss. It sells in the United States, Europe, China, Japan and other markets, often through collaborations and licensing deals with other firms.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the LLY overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Up 4.3% at the close

Above both trend lines; one of the day's strongest moves.

The moving-average stack

vs 20-day+7.5%
vs 50-day+15.8%
vs 200-day+28.2%
52-week band2.8% off the high · +80.7% off the low
Streak1 consecutive up session
Stochastic%K 62.4 · %D 67.3

Continue: the LLY chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on LLY?

Up 4.3% at the close — Above both trend lines; one of the day's strongest moves. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is LLY above its 50-day and 200-day moving averages?

As of 2026-11-09, Eli Lilly and Company trades +15.8% above its 50-day and +28.2% above its 200-day average, with the 20-day +7.5% away.

How far is LLY from its 52-week high?

2.8% below the 52-week high and 80.7% above the 52-week low, as of 2026-11-09.

Mentioned on Closelooknet

Where LLY appears in the diary — 8 pieces, newest first. Every link is our own writing.

Long reads

AI Users — Builders Up 66%, the Companies Using AI FlatReport · 25 Oct 2026

Dailies

Oil — Brent −6.5% on Iran Talks Lifts Stocks; Amazon +5%, Oracle −6% on a $20 Billion RaiseMidday 10 · 2 Nov 2026
Sell-Off — Nasdaq −3%, Chips −8%, Bitcoin −4%, Gold −3%; Only Bonds, Oil and Defensives HoldMidday 10 · 30 Oct 2026
Chips — the open follows Seoul, then turns: chip index from −2.4% to +0.7%; small caps +1.6%Midday 10 · 20 Oct 2026
Chips — SOXX −3.7%, now 20% below its June high; software −2.4% as hot inflation and BlackRock weighMidday 10 · 14 Oct 2026
Oil — Brent +3.4% to $103.64, energy the only strong sector; chips and power generators sold, PepsiCo +1.1%Midday 10 · 8 Oct 2026
Markets — Nasdaq +1.5% before the open even as TLT breaks 78; Tokyo +3.3% on Micron's record quarterMorning 10 · 1 Oct 2026
The ones that hadn't moved — hyperscalers surge, MMYT takes its line, QQQ presses the decision lineMidday 10 · 3 Aug 2026LLY slips 2.85 percent to 1116.13 and crosses below its 50-day average, bearing a disproportionate share of Health Care's weakness — two days before it prints into the calmest reaction record this series covers.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.